Hypozincemia in the early stage of COVID-19 is associated with an increased risk of severe COVID-19.

Date publication

mai 2021

Journal

Clinical nutrition (Edinburgh, Scotland)

Auteurs

Membres identifiés du Cancéropôle Est :
Pr GUEANT Jean-Louis

Tous les auteurs :
Fromonot J, Gette M, Ben Lassoued A, Guéant JL, Guéant-Rodriguez RM, Guieu R

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/34134916

Résumé

Nutritional predisposition to severe coronavirus disease 2019 (COVID-19) remains unclear. Zinc deficiency could be critical since it is associated with a higher susceptibility to infections. We evaluated the prevalence of hypozincemia in the early stage of COVID-19, its association with risk factors for severe COVID-19 and its prognostic value for hospitalization for respiratory complications within 10 days.

Mots clés

COVID-19, Inflammation, Lymphopenia, Risk factor, Selenium, Zinc

Référence

Clin Nutr. 2021 May 4;: